JP7235741B2 - 抗菌性アミノグリコシド類似体の合成 - Google Patents

抗菌性アミノグリコシド類似体の合成 Download PDF

Info

Publication number
JP7235741B2
JP7235741B2 JP2020522054A JP2020522054A JP7235741B2 JP 7235741 B2 JP7235741 B2 JP 7235741B2 JP 2020522054 A JP2020522054 A JP 2020522054A JP 2020522054 A JP2020522054 A JP 2020522054A JP 7235741 B2 JP7235741 B2 JP 7235741B2
Authority
JP
Japan
Prior art keywords
formula
compound
solvate
salt
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020522054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021500354A (ja
JP2021500354A5 (https=
Inventor
ライッサ トレンド，
マイケル ダッペン，
クリストファー イー． ヘンリー，
アダム アーロン ゴールドブルーム，
ジェイムズ ブラッドリー アッゲン，
リカルド フィリペ デ ジェズス ゴンサルベス メンドンサ，
ジョアン カルロス ファルソン サルディニャ，
Original Assignee
シプラ ユーエスエイ， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シプラ ユーエスエイ， インコーポレイテッド filed Critical シプラ ユーエスエイ， インコーポレイテッド
Publication of JP2021500354A publication Critical patent/JP2021500354A/ja
Publication of JP2021500354A5 publication Critical patent/JP2021500354A5/ja
Priority to JP2023027439A priority Critical patent/JP2023054316A/ja
Application granted granted Critical
Publication of JP7235741B2 publication Critical patent/JP7235741B2/ja
Priority to JP2025015211A priority patent/JP2025062009A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
    • C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
    • C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
    • C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
    • C07H15/236—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2 a saccharide radical being substituted by an alkylamino radical in position 3 and by two substituents different from hydrogen in position 4, e.g. gentamicin complex, sisomicin, verdamycin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2020522054A 2017-10-19 2018-10-18 抗菌性アミノグリコシド類似体の合成 Active JP7235741B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2023027439A JP2023054316A (ja) 2017-10-19 2023-02-24 抗菌性アミノグリコシド類似体の合成
JP2025015211A JP2025062009A (ja) 2017-10-19 2025-01-31 抗菌性アミノグリコシド類似体の合成

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762574544P 2017-10-19 2017-10-19
US62/574,544 2017-10-19
PCT/US2018/056536 WO2019079613A1 (en) 2017-10-19 2018-10-18 SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023027439A Division JP2023054316A (ja) 2017-10-19 2023-02-24 抗菌性アミノグリコシド類似体の合成

Publications (3)

Publication Number Publication Date
JP2021500354A JP2021500354A (ja) 2021-01-07
JP2021500354A5 JP2021500354A5 (https=) 2021-11-18
JP7235741B2 true JP7235741B2 (ja) 2023-03-08

Family

ID=64110232

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020522054A Active JP7235741B2 (ja) 2017-10-19 2018-10-18 抗菌性アミノグリコシド類似体の合成
JP2023027439A Withdrawn JP2023054316A (ja) 2017-10-19 2023-02-24 抗菌性アミノグリコシド類似体の合成
JP2025015211A Pending JP2025062009A (ja) 2017-10-19 2025-01-31 抗菌性アミノグリコシド類似体の合成

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2023027439A Withdrawn JP2023054316A (ja) 2017-10-19 2023-02-24 抗菌性アミノグリコシド類似体の合成
JP2025015211A Pending JP2025062009A (ja) 2017-10-19 2025-01-31 抗菌性アミノグリコシド類似体の合成

Country Status (11)

Country Link
US (3) US11453658B2 (https=)
EP (1) EP3697797A1 (https=)
JP (3) JP7235741B2 (https=)
CN (1) CN111655709B (https=)
AR (1) AR113780A1 (https=)
AU (2) AU2023219819B2 (https=)
CA (1) CA3079508A1 (https=)
EA (1) EA202090980A1 (https=)
MX (1) MX2020003701A (https=)
TW (1) TWI801438B (https=)
WO (1) WO2019079613A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023054316A (ja) * 2017-10-19 2023-04-13 シプラ ユーエスエイ， インコーポレイテッド 抗菌性アミノグリコシド類似体の合成

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110878108B (zh) * 2019-06-17 2022-11-11 山东安信制药有限公司 一种普拉佐米星的合成方法
CN110885350A (zh) * 2019-08-28 2020-03-17 山东安信制药有限公司 一种普拉佐米星的制备方法
CN110642907B (zh) * 2019-10-12 2020-11-06 上海博璞诺科技发展有限公司 普拉唑米星或其盐的合成方法
CN111116688B (zh) * 2020-01-07 2021-07-27 杭州华东医药集团新药研究院有限公司 普拉佐米星的制备方法
CN111205341A (zh) * 2020-02-17 2020-05-29 山东安信制药有限公司 一种普拉佐米星关键中间体的制备方法
CN112079882B (zh) * 2020-10-10 2021-10-08 山东安信制药有限公司 一种Plazomicin的制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100204280A1 (en) 2007-05-29 2010-08-12 Universite De Montreal Cinnamoyl inhibitors of transglutaminase
WO2010132770A1 (en) 2009-05-14 2010-11-18 Achaogen, Inc. Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
WO2010147836A1 (en) 2009-06-17 2010-12-23 Achaogen, Inc. Combination therapies using antibacterial aminoglycoside compounds
JP2011504508A (ja) 2007-11-21 2011-02-10 アカオジェン インコーポレイテッド 抗菌性アミノグリコシド類似体
WO2011143497A1 (en) 2010-05-12 2011-11-17 Rempex Pharmaceuticals, Inc. Aminoglycoside derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4388233A (en) * 1981-05-15 1983-06-14 The Regents Of The University Of California Synthetic substrates for enzyme analysis
MX2009003909A (es) 2006-10-12 2009-05-25 Ptc Therapeutics Inc Métodos para dosificar un compuesto 1,2,4, - oxadiazol oralmente activo para el tratamiento de supresión de la mutación finalizadora.
EP2103602A1 (en) * 2008-03-17 2009-09-23 AEterna Zentaris GmbH Novel 1,2,4-triazole derivatives and process of manufacturing thereof
CA2761756A1 (en) * 2009-05-14 2010-11-18 Achaogen, Inc. Treatment of urinary tract infections with antibacterial aminoglycoside compounds
US9238670B2 (en) * 2013-03-15 2016-01-19 The Board Of Trustees Of The Leland Stanford Junior University Aminoglycoside antibiotics with reduced ototoxicity
WO2019079613A1 (en) * 2017-10-19 2019-04-25 Achaogen, Inc. SYNTHESIS OF ANTIBACTERIAL AMINOGLYCOSIDE ANALOGUES

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100204280A1 (en) 2007-05-29 2010-08-12 Universite De Montreal Cinnamoyl inhibitors of transglutaminase
JP2011504508A (ja) 2007-11-21 2011-02-10 アカオジェン インコーポレイテッド 抗菌性アミノグリコシド類似体
WO2010132770A1 (en) 2009-05-14 2010-11-18 Achaogen, Inc. Treatment of klebsiella pneumoniae infections with antibacterial aminoglycoside compounds
WO2010147836A1 (en) 2009-06-17 2010-12-23 Achaogen, Inc. Combination therapies using antibacterial aminoglycoside compounds
WO2011143497A1 (en) 2010-05-12 2011-11-17 Rempex Pharmaceuticals, Inc. Aminoglycoside derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J. Org. Chem.，2008年，73(15)，5766-5775，DOI: 10.1021/jo8004843

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023054316A (ja) * 2017-10-19 2023-04-13 シプラ ユーエスエイ， インコーポレイテッド 抗菌性アミノグリコシド類似体の合成

Also Published As

Publication number Publication date
AR113780A1 (es) 2020-06-10
CN111655709A (zh) 2020-09-11
US12122769B2 (en) 2024-10-22
US20250122177A1 (en) 2025-04-17
US20230074115A1 (en) 2023-03-09
AU2018353156A1 (en) 2020-05-07
EP3697797A1 (en) 2020-08-26
JP2025062009A (ja) 2025-04-11
MX2020003701A (es) 2020-07-22
EA202090980A1 (ru) 2020-10-07
CN111655709B (zh) 2024-01-02
JP2021500354A (ja) 2021-01-07
WO2019079613A1 (en) 2019-04-25
CA3079508A1 (en) 2019-04-25
US20200317652A1 (en) 2020-10-08
RU2020116171A (ru) 2021-11-19
AU2023219819A1 (en) 2023-09-07
BR112020007740A2 (pt) 2020-10-13
AU2025226793A1 (en) 2025-09-25
JP2023054316A (ja) 2023-04-13
TWI801438B (zh) 2023-05-11
US11453658B2 (en) 2022-09-27
TW201922233A (zh) 2019-06-16
RU2020116171A3 (https=) 2022-03-03
AU2023219819B2 (en) 2025-06-05

Similar Documents

Publication Publication Date Title
JP7235741B2 (ja) 抗菌性アミノグリコシド類似体の合成
AU2022203506B2 (en) PROCESS FOR PREPARING 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES AND SYNTHETIC INTERMEDIATES THEREOF
JP6954959B2 (ja) 抗ウイルス化合物を調製するためのプロセス
AU2016289061B2 (en) Method for producing 7H-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
CN105849118B (zh) 大环hcv ns3抑制三肽的合成
CA3044796A1 (en) Method for preparing 7h-pyrrolo[2,3-d]pyrimidine derivatives andd co-cryco-crystals thereof
CN118085015A (zh) 作为蛋白降解剂的并环类化合物及其制备方法和用途
RU2798844C2 (ru) Синтез антибактериальных аминогликозидных аналогов
CN117677616A (zh) 制备血红蛋白调节剂的方法
EA043984B1 (ru) Синтез антибактериальных аминогликозидных аналогов
HK40029080B (zh) 抗菌氨基糖苷类似物的合成
HK40029080A (en) Synthesis of antibacterial aminoglycoside analogs
BR122025029166A2 (pt) Processos para síntese de compostos análogos de aminoglicosídeos antibacterianos e os ditos compostos
BR112020007740B1 (pt) Processos para síntese de compostos análogos de aminoglicosídeos antibacterianos e os ditos compostos
WO2021148793A1 (en) Process for the preparation of purine derivatives exhibiting cdk inhibitory activity
WO2026090412A1 (en) BUILDING BLOCKS FOR GAINAc-BASED LIPIDS
BR112017021926B1 (pt) Processo para a preparação de derivados de ácido galnac, sal de amina e processo para a preparação de conjugados de oligonucleotídeos galnac
HK40022676A (en) Synthesis of a macrocyclic hcv ns3 inhibiting tripeptide
HK40022676B (en) Synthesis of a macrocyclic hcv ns3 inhibiting tripeptide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20211008

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20211008

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220927

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230124

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230224

R150 Certificate of patent or registration of utility model

Ref document number: 7235741

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250